Timothy M. Kuzel
Clinical Professor · Feinberg School of Medicine
Credentials: · · · ·
History
Research
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Journal of Clinical Oncology · 2015 · 901 citations
Journal of Clinical Oncology · 2007 · 833 citations
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma
New England Journal of Medicine · 2011 · 677 citations
55 papers
39 papers
22 papers
20 papers
- HR
17 papers
- MD
16 papers
- MT
15 papers
- RM
15 papers
Grants
- 2008–2015
National Cancer Institute · P50
Project lead · $1.3M · Northwestern University
- 2007–2013
The Robert H. Lurie Comprehensive Cancer Center
National Cancer Institute · P30
Project lead · $2.7M · Northwestern University
- 2001–2004
In vivo Generation of Angiostatin 4.5--Clinical Trial
National Cancer Institute · R21
Contact PI · $536.8K · Northwestern University
- 1997–1998
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $58.3K · Northwestern University
Clinical trials
- 2020
Low-moderate Intensity Pedaling During Immunotherapy Administration
Principal investigator · Withdrawn
Rush University Medical Center
- 2008–2011
Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL
Principal investigator · Terminated
Northwestern University
- 2008–2013
Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Principal investigator · Terminated
Northwestern University
- 2008
Principal investigator · Unknown · Phase 1
Advanced Life Sciences, Inc.